Lanax

Quick links to important sections

Lanax

Treatment option:

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Lanax

Property Description
Active ingredient Timolol and Travoprost (Synthetic)
Form Ophthalmic solution (Eye drop)
Pharmacological class Ocular Hypotensive Agent (Beta-blocker / Prostaglandin Analogue)
Common use Reduction of elevated intraocular pressure (IOP)
Rx Status Prescription-only medicine

Lanax is a foundational prescription-only medicine designed for the therapeutic management of high pressure inside the eye, functioning as an ocular hypotensive agent. This preparation is a synthetic ophthalmic solution, formulated as an eye drop for topical ocular administration. It is characteristic of a fixed-dose combination product, an advanced approach that unites two active components in a single bottle.

Defining Lanax: Identity and Classification

Lanax is specifically classified as an antiglaucoma drug intended to achieve a significant reduction of elevated pressure within the eye. Its composition delivers two agents from distinct pharmacological classes: the beta-adrenergic receptor antagonist Timolol (a beta-blocker) and the synthetic fatty acid derivative Travoprost (a prostaglandin analogue). The combination of Travoprost/Timolol is clinically recognized for its robust IOP-lowering effectiveness compared to using either component alone. This combination is intended to provide comprehensive pressure control. Popular brands worldwide employing this same dual formulation include DuoTrav and Travacom.

Composition and General Purpose

The active compounds, Timolol maleate and Travoprost, are delivered via an aqueous base as a clear, sterile liquid eye drop. The use of a fixed combination provides a crucial differentiating factor: it offers a solution for adult patients with open-angle glaucoma or ocular hypertension who have not achieved sufficient pressure reduction with monotherapy. This pairing represents an established treatment approach for controlling intraocular pressure. This combination represents an approved standard for intensified management of eye pressure. The ultimate purpose of Lanax is the sustained reduction of elevated intraocular pressure (IOP), leveraging Timolol to decrease aqueous humour production and Travoprost to concurrently increase uveoscleral outflow, or drainage, thereby regulating the full dynamic system of ocular fluid.

What side effects are possible with Lanax?

Possible side effects and safety information

The safety profile of Lanax, a fixed-dose combination of Travoprost and Timolol, is established through official regulatory documentation, which classifies adverse reactions based on frequency and affected physiological system. The safety profile reflects both local effects from the prostaglandin analogue (Travoprost) and the potential for systemic effects from the absorbed beta-blocker (Timolol).


Adverse Reactions by Frequency

Frequency Classification Representative Adverse Reactions
Very Common (ge 10%) Ocular hyperaemia (redness of the eye)
Common (ge 1% to <10%) Eye pain, eye pruritus, ocular discomfort, dry eye, headache
Uncommon (ge 0.1% to <1%) Iritis, dizziness, bradycardia (slow heart rate), hypotension, dyspnoea (shortness of breath)

Systemic Safety Concerns

Adverse reactions are formally grouped into categories such as Eye disorders, Cardiac disorders, Vascular disorders, Respiratory, thoracic and mediastinal disorders, and Nervous system disorders. Serious adverse reactions primarily relate to the systemic absorption of the beta-blocker component, including the potential for severe cardiorespiratory events such as bronchospasm and cardiac failure.

Safety-related restrictions mandate that the medicine is contraindicated in patients with a history of bronchial asthma, severe chronic obstructive pulmonary disease (COPD), sinus bradycardia, or overt cardiac failure. Furthermore, certain changes, notably the increase in iris pigmentation and alteration of eyelashes, are officially documented as gradual and associated with long-term exposure to the Travoprost component.

Overdose and Emergency Response

Overdose and when to seek help: Official Regulatory Information

The overdose profile for Lanax (Timolol/Travoprost) is defined by the potential systemic effects of the Timolol beta-blocker component, which can be absorbed following accidental oral ingestion or excessive topical ocular use. The regulatory documents outline specific manifestations and mandated emergency actions to address this risk.

Property Documented Overdose Manifestations
Cardiovascular/CNS Effects Bradycardia (slowed heart rate), hypotension (low blood pressure), dizziness, and headache are reported signs [1.4, 2.3].
Severe Outcomes The potential for severe A-V block, cardiac arrest, and life-threatening bronchospasm is officially noted [2.5].

Emergency Response and Management

Official instructions require action for suspected overdose or severe symptoms. You must seek immediate medical attention or contact a poison control center/emergency room at once if ingestion occurs or if symptoms are severe [2.4, 3.1]. Call emergency services immediately if the affected person collapses, has a seizure, or is experiencing trouble breathing [3.1].

Management is documented as symptomatic and supportive treatment, focusing on close medical supervision and monitoring of heart rate and blood pressure [3.3]. No specific antidote for systemic overdose is known, and hospitalization may be required [2.3, 3.3]. The drug must be discontinued at the first sign or symptom of cardiac failure [1.4].

Therapeutic Uses of Lanax

Quick Facts: Lanax

  • Relieves symptoms of Generalized Anxiety Disorder (GAD).
  • Assists in managing Panic Disorder (PD) episodes.
  • Contributes to treatment for Social Anxiety Disorder (SAD).

What Lanax Treats: Main Uses and Benefits

Lanax is a prescription medication utilized in therapeutic regimens to manage the symptoms associated with certain anxiety disorders. It is indicated to provide relief from the excessive worry and tension experienced by individuals with Generalized Anxiety Disorder (GAD). The medication may help alleviate the symptoms of panic disorder, characterized by recurrent, unexpected panic attacks and the constant concern over having future episodes.

Furthermore, Lanax is an option to consider for addressing Social Anxiety Disorder (SAD), where it supports efforts to reduce the intense fear of social situations and performance-related anxiety. It can be used to promote a state of calm in patients who may benefit from short-term assistance with anxiety. This medication is part of a comprehensive treatment plan and may be administered alongside psychotherapy or other interventions.

These represent the recognized therapeutic uses and indications for the medication.

Eligibility and Restrictions for Use

Who Can and Cannot Use Lanax?

Lanax (Travoprost/Timolol) eligibility is defined by strict regulatory guidelines, primarily focusing on systemic health status and age, as documented by authorities like the FDA and EMA. Use is generally restricted to adult patients with open-angle glaucoma or ocular hypertension. Geriatric patients are also eligible, provided no contraindications exist.


Absolute Contraindications

Use is absolutely prohibited for patients with specific cardiac and respiratory conditions due to the systemic risk posed by the Timolol component (a beta-blocker). This includes patients with:

  • Bronchial Asthma or a history of asthma.
  • Severe Chronic Obstructive Pulmonary Disease (COPD).
  • Severe cardiac disorders, such as Sinus Bradycardia, Overt Cardiac Failure, or Second- or Third-Degree AV Block.
  • Known hypersensitivity to the active ingredients or any excipients.

Restricted Populations

  • Pregnancy: The medication must not be used by women during pregnancy or those attempting to become pregnant, due to the Travoprost component.
  • Pediatric Population: Use in children and adolescents below 18 years is not recommended as safety and efficacy have not been established.
  • Conditional Use: Caution is mandated for patients with labile diabetes, risk factors for macular edema (e.g., aphakic patients), or those with existing active intraocular inflammation.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official regulatory profile for Lanax interactions is structured around two primary mechanisms: pharmacodynamic reinforcement and CYP3A4-mediated pharmacokinetic alteration.

Contraindicated and Restricted Combinations

Co-administration with Opioid analgesics is associated with an official regulatory warning due to the severe risk of additive respiratory depression and profound sedation. The combination of Lanax with strong CYP3A4 inhibitors (such as ketoconazole or itraconazole) is formally restricted or prohibited because these agents significantly increase Lanax systemic exposure by reducing its metabolic clearance.

Pharmacodynamic and Metabolic Interactions

Co-administration with other Central Nervous System (CNS) depressants (e.g., antipsychotics, hypnotics, sedating antihistamines, and alcohol) results in officially documented additive sedative effects. The use of alcohol is specifically prohibited due to this pharmacodynamic reinforcement. Substances that inhibit the CYP3A4 enzyme, such as cimetidine or fluoxetine, are documented to increase the drug’s plasma concentration, while CYP3A4 inducers (e.g., rifampin) can decrease exposure.

Substance and Population Notes

The consumption of Grapefruit juice is noted to interact with the CYP3A4 pathway, potentially increasing plasma levels. Regulatory documents also specify that the clinical relevance of these interactions is heightened in elderly patients and individuals with hepatic impairment, as reduced clearance may exacerbate exposure-related effects.

Mechanism of Action

How Lanax Works: Mechanism of Action

Lanax, following bioactivation in the eye, acts as an agonist by binding to specific prostaglandin F2alpha ( FP) receptors located on the ciliary muscle and surrounding tissues. This targeted interaction initiates a cellular signaling cascade within the ocular structures responsible for aqueous humor outflow.

The receptor activation leads to increased transcription and activity of matrix metalloproteinases ( MMPs). These enzymes remodel the extracellular matrix of the ciliary muscle bundles, causing a structural change that enhances the permeability of the tissue. This physiological consequence increases the rate of aqueous humor clearance through the uveoscleral outflow pathway. The enhanced fluid drainage subsequently results in the reduction of intraocular pressure.

Dosage and Administration Information

Lanax is a fixed-dose combination ophthalmic solution for topical ocular administration. The medicine is supplied as a sterile eye drop combining Travoprost and Timolol.

Official Dosing and Frequency

Population Dose Frequency
Adults (including Elderly) One drop in the affected eye(s) Once daily, at the same time each day
Pediatric Patients (<18 years) Not recommended Not applicable

Do not use more than one drop daily in the affected eye(s), as more frequent dosing of the Travoprost component may reduce its effectiveness. If a dose is missed, continue the course with the next dose as planned; do not use a double dose.

Administration and Procedural Rules

The following procedural rules are established to ensure proper application:

  • Contact Lenses: Soft contact lenses must be removed before instilling the drops and may be reinserted 15 minutes after application.
  • Coadministration: If using other topical eye medications, they must be administered at least 5 minutes apart.
  • Systemic Absorption: Immediately after instillation, nasolacrimal occlusion (pressure on the inner corner of the eye) or gentle eye closing for about 2 minutes should be performed to reduce the medicine’s absorption into the bloodstream.
  • Contamination: Do not allow the tip of the dropper to touch the eye, eyelids, or any other surface.

Special Populations: No dose adjustment is generally necessary for patients with mild to severe hepatic or renal impairment.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Lanax

Evidence for Use in Elevated Intraocular Pressure (IOP)

Clinical research on Lanax, which is a fixed combination of Travoprost and Timolol, was studied for the reduction of elevated pressure inside the eye in conditions specifically, including open-angle glaucoma and ocular hypertension. These studies primarily involve adult patients whose eye pressure needs to be managed. Researchers conducted multiple Randomized Controlled Trials (RCTs) to evaluate the fixed combination. This type of study research involved randomly assigning patients to different treatment groups.

The primary focus of these trials was the measurement of Intraocular Pressure (IOP). Studies recorded how pressure measurements changed in the observed populations over defined time intervals. Research has explored the diurnal IOP patterns, meaning they took pressure readings at various times throughout the day, such as morning, midday, and afternoon. This approach evidence contributes to understanding IOP measurement consistency.

Comparing Lanax to Monotherapies and Other Treatments

Researchers designed studies to compare the fixed Travoprost/Timolol combination against using each active ingredient alone (monotherapies). This research helps contextualize how patients reported their experience when using the combination compared to single-ingredient options.

In these comparative research scenarios, research examined how IOP measurements differed between the combination product and the monotherapy products. Some trials also was studied for how the combination compared to administering the two ingredients separately at the same time (unfixed concomitant therapy). Data show patterns related to IOP measurements when using the fixed combination versus using the individual eye drops.

Evidence Gaps and Research Uncertainty

Despite the research base supporting the study of the Travoprost/Timolol combination, some areas of research remain uncertain. For example, comparative evidence is lacking for large-scale, head-to-head randomized studies that directly assess this specific fixed combination against every other available fixed-dose combination eye drop.

Another key limitation is that there is limited information for long-term outcomes relating to the actual progression of optic nerve damage over many years. The evidence is limited for long-term prognostic predictions related to vision preservation.

Key Studies & References

  1. Travoprost/Timolol fixed combination for elevated intraocular pressure: a systematic review and meta-analysis

Frequently Asked Questions (FAQ)

Common questions about Lanax (FAQ)


Q: Is Lanax a type of antibiotic?

Lanax is an ocular hypotensive agent used specifically for the management of elevated pressure inside the eye, such as in open-angle glaucoma. It is not an antibiotic. It is a fixed-dose combination of two medicines: a prostaglandin analog (Travoprost) and a beta-blocker (Timolol).


Q: Does Lanax have a generic version available?

The fixed combination of Travoprost and Timolol is marketed globally under various brand names. In many regions, generic fixed-dose formulations of the same active ingredients are also available. A healthcare provider is responsible for determining the specific brand or generic formulation appropriate for a prescription.


Q: How quickly should I expect Lanax to start working?

Studies indicate that the pressure-lowering effect in the eye typically begins within 30 minutes to two hours after a single dose. The maximum therapeutic reduction in intraocular pressure ( IOP) is generally observed approximately 12 hours after application. Since this medicine treats internal pressure, the effect is typically not felt by the user.


Q: Is Lanax considered a high-risk medication?

Lanax is a medicine that requires careful consideration due to the systemic effects of the Timolol component (a beta-blocker). Official warnings state that it is strictly prohibited (contraindicated) for patients with pre-existing serious medical conditions, including severe cardiac disorders and certain severe respiratory conditions like asthma. This is because of the potential for serious cardiorespiratory adverse events.


Q: Is Lanax used for treating pain?

Lanax is approved and indicated solely for the therapeutic reduction of elevated intraocular pressure ( IOP) in conditions like open-angle glaucoma or ocular hypertension. It is not an analgesic and is not used for the treatment of pain.


Q: What should I do if Lanax doesn't seem to be working?

The medicine works to reduce pressure inside the eye, which is a process that patients generally do not feel. Its effectiveness is determined by an eye care professional through regular measurement of intraocular pressure. If concerns arise about the medicine's performance or if a patient experiences new ocular trauma or conditions, regulatory documents advise seeking professional medical advice immediately.


Q: Do other medications need to be stopped before starting Lanax?

Prior to starting Lanax, official guidance states that all current medications must be disclosed to a healthcare provider, as some combinations are strictly prohibited (contraindicated). This is especially true for oral beta-blockers and certain strong inhibitors of the CYP3A4 enzyme, as taking these together can lead to dangerous interactions. A healthcare provider is responsible for reviewing the patient’s medication list and determining if any adjustments are necessary.


Q: Can I drive or operate machinery while taking Lanax?

According to the official product information, temporary blurred vision or dizziness can occur right after applying the eye drops. If these visual disturbances or dizziness occur, official guidance advises that one should wait until these effects have completely passed before driving or operating machinery.


Q: How long does Lanax stay in your system after stopping it?

The active ingredients are absorbed into the body’s bloodstream, where they are metabolized and eliminated. The Timolol component has an average plasma half-life of approximately 5 hours once a steady state is reached. The Travoprost component is eliminated even more rapidly, meaning that it generally clears from the body within a short period after treatment stops.


Q: Are there different strengths or forms of Lanax?

Lanax is formulated as a fixed-dose combination ophthalmic solution (eye drops). It is generally supplied in a single regulatory approved strength, typically containing Travoprost 0.004% and Timolol 0.5%.


Q: Is Lanax a controlled substance?

Lanax is a prescription-only medicine, meaning it must be dispensed by a licensed pharmacist upon a written prescription. It is not, however, classified as a scheduled controlled substance by regulatory bodies like the U.S. Drug Enforcement Administration ( DEA).


Q: Do I need a special blood test before starting Lanax?

Official product information does not mandate that patients undergo routine blood testing before beginning treatment with Lanax. However, because the medicine can have systemic effects, a healthcare provider assesses a patient's overall health, especially where conditions like labile diabetes exist.


Q: Can Lanax interact with herbal supplements?

While specific interactions with every herbal supplement have not been formally studied, Lanax is known to interact with the CYP3A4 metabolic enzyme pathway. For this reason, official patient counseling information advises that all supplements, including herbal remedies and vitamins, should be disclosed to a healthcare provider.


Q: What is the average duration of treatment with Lanax?

Lanax is approved and designed for the sustained, long-term therapeutic management of high pressure inside the eye. Treatment is often continued indefinitely to maintain control of intraocular pressure, with clinical studies following patients for one year or longer. Any decision to stop or change the duration of treatment is a clinical matter to be determined by a healthcare professional.


Q: Why is it important to take Lanax exactly as prescribed?

Taking the medicine exactly as prescribed (once daily) is important because using it more frequently may actually reduce the effectiveness of the pressure-lowering component. Following the administration rules is also necessary to avoid contaminating the dropper tip, which could introduce bacteria and potentially cause serious eye infections.


Q: Is there a risk of dependence or addiction with Lanax?

Official regulatory documents that describe the drug's safety profile do not indicate or list any known risk of physical dependence or addiction associated with the use of Lanax ophthalmic solution.


Q: How is Lanax different from a common over-the-counter medicine?

Lanax is classified as a prescription-only medicine because it is used to manage serious, chronic conditions like ocular hypertension and glaucoma. Unlike common over-the-counter products, its use requires ongoing supervision by a doctor to monitor its effects on eye pressure and overall systemic health.


Q: Can Lanax be taken with multivitamins?

Multivitamins are not specifically listed as an interacting substance in the official documents. However, general patient counseling guidance advises that all supplements, including multivitamins, should be disclosed to a healthcare provider.


Q: Are there specific symptoms that mean I should stop taking Lanax?

Severe reactions related to the heart or lungs, such as experiencing severe difficulty breathing or a significant slowing of the heart rate, require immediate medical attention. The medicine is strictly prohibited (contraindicated) for patients with serious pre-existing conditions like severe asthma or overt cardiac failure.


Q: Is Lanax ever used 'off-label'?

The medicine is approved by regulatory agencies only for its specific indicated purpose: the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension. Official regulatory documents do not provide information on or confirm any other uses of the medicine.


Q: Can Lanax cause stomach upset or nausea?

While the medicine is applied to the eye, some systemic absorption occurs, and gastrointestinal side effects have been reported rarely. Specifically, effects like indigestion or upset stomach have been noted in the safety profile of the beta-blocker component (Timolol).


Q: Why does my prescription bottle for Lanax have a specific warning label?

Regulatory agencies mandate the use of warning labels to ensure that critical safety and administration information is clearly visible to patients. These labels draw attention to important points, such as the need to protect the dropper tip from contamination or the potential for systemic side effects from the beta-blocker component.


Q: Is it safe to stop Lanax suddenly?

Because Lanax is used for the chronic management of high eye pressure, sudden discontinuation is strongly discouraged. Stopping the medicine without medical guidance could lead to an uncontrolled, damaging rise in intraocular pressure. The decision to stop treatment must be made by a healthcare professional.


Q: Does Lanax affect my energy levels?

The systemic absorption of the Timolol component, which is a beta-blocker, may rarely result in effects such as fatigue. Other nervous system effects that have been reported include nervousness and dizziness.


Q: Can Lanax cause issues with sleeping?

Official safety data indicate that insomnia, or difficulty sleeping, has been reported as an uncommon psychiatric side effect of the Travoprost component. Any difficulty sleeping experienced while using the medicine should be discussed with the prescribing healthcare provider.


Q: Can Lanax be taken for long periods of time?

Yes, the medicine is designed and approved for the sustained, long-term management of elevated eye pressure. Due to its long-term nature, patients are regularly monitored for specific long-term effects, such as the gradual increase in the pigmentation (darkening) of the iris of the treated eye.


Q: Is it normal to feel a little dizzy when starting Lanax?

Dizziness is listed in the official safety profile as an uncommon side effect of the medicine. Since it is not experienced by most patients, if you do feel dizzy, regulatory documents advise against activities like driving or operating machinery until the symptom has completely passed.


Q: Are there any specific foods or drinks to avoid while using Lanax?

The consumption of alcohol is strictly prohibited because it can cause additive sedative effects when combined with this medicine. Grapefruit juice is also noted in some regulatory documents because it may increase the concentration of the medicine in the body by interfering with its metabolic breakdown.


Q: Does taking Lanax affect blood pressure?

The systemic absorption of the beta-blocker component (Timolol) can potentially affect the cardiovascular system. Official safety documents list side effects that include a slowing of the heart rate (bradycardia) and low blood pressure (hypotension).


Q: Can Lanax be used during pregnancy or while breastfeeding?

Use of Lanax is strictly prohibited (contraindicated) during pregnancy due to regulatory warnings concerning the Travoprost component. The medicine is also generally not recommended for use while breastfeeding because the Timolol component is known to be excreted in human milk.


Q: Does Lanax have any known severe allergic reactions?

The medicine is strictly prohibited (contraindicated) for anyone with a known hypersensitivity (severe allergic tendency) to its active ingredients or any inactive components. Official safety profiles also note that severe systemic allergic reactions have been reported in connection with the Timolol component.


Q: Can older adults use Lanax safely?

Older adults are generally eligible to use this medicine for the reduction of elevated eye pressure. However, official information notes that the risk and clinical relevance of drug interactions may be heightened in elderly patients due to potentially reduced clearance of the medicine from the body.


Q: Is it true that Lanax can change my mood?

Psychiatric effects, including depression and anxiety, have been reported as uncommon side effects in the official safety profile. Any changes in mood or emotional state experienced should be discussed with a healthcare provider.


Q: Does Lanax interact with common cold medicines?

Lanax is known to have additive effects when combined with Central Nervous System ( CNS) depressants. This class includes some common cold and allergy medicines that contain ingredients like sedating antihistamines. The combination may result in increased sedative effects; therefore, a healthcare provider should review all cold and flu products being used.


Q: Are there any rare side effects of Lanax I should know about?

The official safety profile lists several less common side effects (uncommon, less than 1% of patients), such as inflammation of the eye (iritis), low blood pressure (hypotension), and slow heart rate (bradycardia). Rare but serious side effects include cardiorespiratory events, which is why the medicine is contraindicated for patients with severe heart or lung conditions.


Q: Can I take Lanax if I have diabetes?

Caution is advised for patients who have labile (unstable) diabetes. This is because the Timolol component may interfere with the body's natural signs of acute low blood sugar (hypoglycemia), such as a rapid heart rate, making it harder to recognize.

How should Lanax be stored and disposed of?

How to Store and Dispose of Lanax (Timolol/Travoprost)

The storage and handling of Lanax ophthalmic solution are strictly defined to maintain product stability and sterility.

Storage Requirements

Condition Unopened Bottle Opened (In-Use) Bottle
Temperature Refrigerate (2 C to 8 C) Store at Room Temperature (not above 25 C)
Shelf-Life Until Expiration Date Discard 28 days after first opening
Protection Store in original carton, protected from light. Do not freeze. Keep bottle tightly closed; do not refrigerate.

All Lanax must be stored out of the sight and reach of children.

Disposal

Expired or unused product must be disposed of as pharmaceutical waste. The solution must not be thrown away with household trash or poured into wastewater (e.g., sink or toilet).

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Lanax found in:

A-Z Index: